drugset / Trial / NCT02496039
Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)
NaSingle-groupOpen-labelOther
Summary
6 month study of NUEDEXTA ® (Dextromethorphan Hydrobromide and Quinidine Sulfate) for the treatment of Pseudobulbar Affect (PBA) in Nursing Home Patients.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-05
- Completion
- 2016-05
Outcome
Outcome not reported
Stopped (Enrollment): “The study was terminated prematurely because of difficulty with recruiting.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | 20 mg | Oral |
| Subject | Quinidine | Small molecule | 10 mg | Oral |